Eliminating HCV Infection Among PWUD
NCT05474781 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2022-07-26
Summary
Identify 300 PWUD with chronic, viremic HCV infection and engage them in a multidisciplinary, generalizable model of care and initiate HCV treatment
Conditions
- Hepatitis C, Chronic
- Drug Use
Interventions
- DRUG
-
Epclusa
HCV treatment
Sponsors & Collaborators
-
Vancouver Infectious Diseases Centre
lead OTHER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-22
- Primary Completion
- 2023-12-31
- Completion
- 2024-12-31
- FDA Drug
- Yes
Countries
- Canada
Study Locations
More Related Trials
-
The Kentucky Viral Hepatitis Treatment Study
NCT03949764 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacist-led Hepatitis C Management
NCT04322981 ·Status: UNKNOWN ·Phase: PHASE4
-
Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia
NCT03876470 ·Status: UNKNOWN
-
Hepatitis C Pharmacy-based Strategy for Injectors
NCT04698629 ·Status: COMPLETED
-
Eliminate Hepatitis C/EC Partnership Evaluation Protocol
NCT04061551 ·Status: UNKNOWN ·Phase: NA
-
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study
NCT03364725 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals
NCT02933970 ·Status: COMPLETED ·Phase: NA
-
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers
NCT04366973 ·Status: COMPLETED
-
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
NCT00674492 ·Status: COMPLETED
-
HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment
NCT03524794 ·Status: UNKNOWN
-
Hepatitis C Treatment in Underserved Populations
NCT01717560 ·Status: UNKNOWN ·Phase: NA
-
Re-link HCV in Substance-Use Telemedicine Program
NCT06349902 ·Status: RECRUITING
-
Treatment as Prevention for Hepatitis C in Iceland
NCT02647879 ·Status: RECRUITING
-
Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care
NCT03093415 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
NCT00218192 ·Status: COMPLETED ·Phase: PHASE3
-
Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination
NCT05369507 ·Status: COMPLETED ·Phase: NA
-
Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection
NCT03057847 ·Status: COMPLETED ·Phase: PHASE4
-
Pender Assisted Therapy (PATh) - Prospective Study of the Treatment of HCV
NCT00247884 ·Status: COMPLETED
-
Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy
NCT00351871 ·Status: COMPLETED ·Phase: PHASE4
-
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
NCT01474811 ·Status: COMPLETED
-
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
NCT00194480 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Reduce Intravenous Exposures (STRIVE)
NCT00391482 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
NCT05649202 ·Status: WITHDRAWN
-
Increasing HCV Linkage to Care Among People Who Inject Drugs
NCT04741750 ·Status: COMPLETED ·Phase: NA
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4